600420.SS · 国药现代
China A-shares · RS rating 55 · As of 2026-10-14
| Price | 8.55 CNY |
|---|---|
| 1-day change | +1.1% |
| RS rating (overall / 1M / 3M / 12M) | 55 / 80 / 51 / 38 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 30 / 17 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -9.1% |
| Distance from 52-week high | +22.1% |
| Market cap (USD) | $1.7B |